World Wires · story 28766 · unverified · 1 source(s)

Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia

Ad Hoc Announcement Pursuant to Art. 53 LR

Open in the desk

Coverage

• Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia GlobeNewswire: public companies · tier D · clear net · 2026-10-08 05:00 UTC

What this site indexes